Latham & Watkins and Wilson Sonsini Goodrich & Rosati advised Boundless Bio on the offering, and Cooley advised the underwriters. Boundless Bio, Inc. (Nasdaq: BOLD) a clinical...
Boundless Bio’s $100 Million IPO
Lambda’s $500 Million GPU-Backed Facility
Greenberg Traurig represented Lambda in the transaction. The artificial-intelligence (AI) infrastructure company Lambda secured a special purpose graphics processing units (GPU) financing vehicle of up to $500...
Leap Therapeutics’ $40 Million Private Placement
Paul Hastings LLP advised J.P. Morgan Securities LLC as the exclusive placement agent in the transaction. Leap Therapeutics, Inc. (Nasdaq:LPTX) has entered into a securities purchase agreement with...
Century Therapeutics’ $60 Million Private Placement
Paul Hastings LLP advised BofA Securities as the sole placement agent in the transaction. Century entered into a securities purchase agreement with a select group of...
Mesa Royalties III’s Mineral and Royalty Acquisition in the Haynesville Shale Play
Weil, Gotshal & Manges advised Mesa Royalties III Holdings, LLC and affiliates in the deal. Mesa Royalties III Holdings, LLC announced its acquisition of oil and...
Vitaprotech’s $145 Million Acquisition of Identiv
Weil, Gotshal & Manges advised Vitaprotech, while Pillsbury Winthrop Shaw Pittman advised Identiv on the deal. Seven2 portfolio company Vitaprotech announced its acquisition of the physical...
Lithium Americas’ US$275 Million Common Shares Public Offering
Skadden is advising the underwriters in the offering. Lithium Americas Corp.’s announcement of the pricing of its previously announced underwritten public offering of 55,000,000 of its...
McCarthy Capital’s $870 Million Closing of McCarthy VIII
Kirkland & Ellis represented McCarthy Partners Management, LLC in the transaction. McCarthy Partners Management, LLC (McCarthy Capital) announced the closing of its latest flagship fund, McCarthy Capital...
Aeovian Pharmaceuticals’ $50 Million Series A Financing Round
Wilson Sonsini Goodrich & Rosati advised Aeovian Pharmaceuticals on patent matters in connection with the transaction. Aeovian Pharmaceuticals, a clinical-stage biopharmaceutical company, announced it has raised...
Nourish’s $35 Million Series A Funding Round
Sidley Austin represented Nourish in the transaction. Nourish announced it raised US$35 million in Series A funding round led by Index Ventures with participation from Maverick Ventures...
Global Business Travel Group’s $570 Million Acquisition of CWT US
Paul Hastings LLP advised CWT US, LLC in the transaction. Global Business Travel Group, Inc. signed the agreement to acquire CWT US, LLC, a transaction valued at $570...
H.I.G. Capital’s Acquisition of Segers
Paul Hastings advised H.I.G. Capital, while Sheppard Mullin advised Segers on the deal. H.I.G. Capital, a global alternative investment firm with $60 billion of capital under...